Infusion Pumps Market Is Projected To Reach $27,133.7 Million by 2030

The global infusion pumps market was valued at $12,825.9 million in 2021, which is predicted to reach $27,133.7 million by 2030, at a compound annual growth rate of over 8.7% between 2021 to 2030. The surging popularity of home infusion solutions, growing cases of chronic diseases, rising aging population, and increasing prevalence of hospital-acquired illnesses are the key factors responsible for market growth.

The revenue share of the homecare settings category was over 30% in 2021, and the category is predicted to grow at the highest rate in the coming years. This will be due to an increase in the incidence of chronic diseases, such as cardiovascular diseases, respiratory ailments, and diabetes, as well as the increasing older population and high cost of hospitalization.

To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/infusion-pumps-market/report-sample

The accessories and consumables category held the largest share of the infusion pumps market, and this is likely to maintain this position in the coming years. This is owing to the global availability of a wide range of accessories and consumables and their frequent purchases.

The demand for traditional infusion pumps is expected to expand at a CAGR of about 10% in the coming years. This might be due to an increase in the requirement for these pumps in homecare and long-term-care settings for providing antibiotics, analgesics, chemotherapeutic medicines, and hydration fluids.

In 2021, the diabetes management category had an over 30% share of the infusion pumps market, and it is expected to grow in the future. This is credited to the rising global incidence of diabetes and technological advancements.

Get the sample pages of this report at: https://www.psmarketresearch.com/market-analysis/infusion-pumps-market/report-sample

The cases of diabetes are on the rise in Europe, affecting people of all ages. In the EU, around 17 million adults were diagnosed with diabetes in 2000, which reached 35 million in 2019.

Smiths Medical, including its portfolio of vascular access devices, vital care products, syringes, and ambulatory infusion devices, was acquired by ICU Medical Inc. from Smiths Group plc in January 2022.

About P&S Intelligence

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.

Contact:
P&S Intelligence
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.